News

The 2010 Working Group on New TB Drugs Annual Meeting


4 Oct 2010
by Working Group

Working Group on New TB Drugs Annual Meeting

Working Group on New TB Drugs Annual Meeting

The 2010 Annual Meeting will be held on November 12, 2010

Please check this page for continuously updated information.

The WGND will host our annual meeting prior to the start of the 41st Union World Conference on Lung Health (The Union) in Berlin.

WHEN: Friday, November 12, 2010, 7:30am – 1:00pm

WHERE: The Kempinski Hotel Bristol Berlin, http://www.kempinski-berlin.de/en/hotel/

WHY: Review progress of drugs in the Global Pipeline, review WGND 2010 activities, propose and discuss 2011 objectives, and network.

Draft Agenda

*Note: this agenda will always reflect the latest available information. Please check back for updates.

7:30- 8:15 Buffet breakfast and networking

8:15-8:25 Welcome, 2010 Recap

Mel Spigelman/Bill Bishai, Co-Chairs

Co-Chairs will welcome members and introduce agenda for the meeting

8:25-8:35 WGND Website: state-of-the pipeline, blog, resources, grants finder

John Michael Maas, Darby Communications and Lisan Parker, Secretariat

8:35-8:45 WGND Community Representatives: Who we are, What we do, and Why we do it

Albert Makone, WGND Community Representatives

8:45-9:00 GSK-Open Source TB Drug Discovery talk

Martin Pan, Discovery Medicine, Diseases of the Developing World Medicines Development Campus, GlaxoSmithKline R&D

9:00-9:15 NIAID’s new TB R&D initiatives

Christine Sizemore

9:15-9:30 Stop TB Global Plan Revision- New Drugs specifics

Christian Lienhardt, Stop TB Partnership Secretariat, Clinical Trial Capacity Subgroup

9:30-9:45 Coffee Break and networking

9:45-11:15 Roundtable update of major clinical programs

Panel discussion to provide 5-10 min updates on drug progress (consisting of invited speakers from all of the companies conducting clinical trials)

Including:

PNU-100480

SQ109

AZD5847

PA-824

TMC-207

Rifapentine

Linezolid

Gatifloxacin

Moxifloxacin

11:15-12:15 ‘Working’ Lunch (buffet) Subgroup Workshop/Breakout sessions

Subgroups convene to discuss implementation strategies and 2011 initiatives

12:15-12:40 Recap Subgroup Workshop/Breakout sessions

Subgroup leaders present 5 min summary of breakout session discussion

12:40-12:50 Meeting Summary and Adjournment

Mel Spigelman/Bill Bishai, Co-Chairs

1:00pm Shuttle from Kempinski hotel to ICC

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...